10x Genomics Overview
Latest PEG ratio for 10x Genomics: 89.98 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow89.98
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, TXG shows a PEG ratio of 89.98. That is above the Healthcare sector average of 11.77. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 11.77. 10x Genomics is at 89.98, which is higher that average. That is roughly 664.3% above the sector mean. Use the comparison chart on this page to see how TXG stacks up against individual peers as well.
Investors watch TXG's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. 10x Genomics's latest reading is 89.98. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has 10x Genomics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 89.98) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 11.77, while TXG is at 89.98. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
